As the year 2017 is just few days away, many investors are in the process of adjusting their stock picks for the next year,
which could potentially see a corporate
tax reform, higher interest rates, the repeal of the Affordable Care Act and reduced regulation under President-elect Donald
Trump's administration.
Against this backdrop, Benzinga provides a list of 15 stocks with the highest forecast sales growth. The
criteria: trailing 12-month revenue of greater than $20 million. The following list will showcase small and mid-cap companies that
are expected to generate several times better 2017 sales versus last year, as projected by Wall Street consensus.
Our list comprises mainly pharma and energy firms. Many pharma companies will see accelerated revenue from new products and
licensing deals, while an expected rise in oil prices is a positive catalyst for the entire energy sector. In particular, several
energy firms may restart potential growth projects, which have been idled during the commodity price downturn.
Following is the list of 15 names set to deliver highest sales growth in 2017.
|
Symbol
|
Name
|
Revenue (TTM), In Millions
|
Revenue Est. For Current Fiscal Year, In Millions
|
Revenue Est. For Next Fiscal Year, In Millions
|
|
AINC
|
Ashford Inc (NYSE: AINC)
|
64.98
|
65.70
|
167.90
|
|
ARLZ
|
Aralez Pharmaceuticals Inc (NASDAQ: ARLZ)
|
40.23
|
56.12
|
141.35
|
|
CQH
|
Cheniere Energy Partners LP Holdings LLC (NYSE: CQH)
|
20.34
|
20.35
|
201.60
|
|
CQP
|
Cheniere Energy Partners LP (NYSE: CQP)
|
616.90
|
985.35
|
2,746
|
|
ERII
|
Energy Recovery, Inc. (NASDAQ: ERII)
|
53.05
|
49.72
|
117.65
|
|
ESTE
|
Earthstone Energy Inc (NYSE: ESTE)
|
35.52
|
43.11
|
129.39
|
|
EVHC
|
Envision Healthcare Holdings Inc (NYSE: EVHC)
|
3,010
|
3,715
|
10,710
|
|
GLNG
|
Golar LNG Limited (USA) (NASDAQ: GLNG)
|
80.19
|
85.53
|
208.78
|
|
KITE
|
Kite Pharma Inc (NASDAQ: KITE)
|
22.15
|
22.72
|
61.30
|
|
LNG
|
Cheniere Energy, Inc. (NYSE: LNG)
|
780.01
|
1,311
|
3,726
|
|
OMED
|
Oncomed Pharmaceuticals Inc (NASDAQ: OMED)
|
25.77
|
26.56
|
90.04
|
|
OREX
|
Orexigen Therapeutics, Inc. (NASDAQ: OREX)
|
24.76
|
33.96
|
84.57
|
|
PHMD
|
PhotoMedex Inc (NASDAQ: PHMD)
|
47.03
|
90.82
|
248.42
|
|
TSRO
|
TESARO Inc (NASDAQ: TSRO)
|
40.83
|
47.04
|
131.90
|
|
TXMD
|
TherapeuticsMD Inc (NYSE: TXMD)
|
20.50
|
20.77
|
49.14
|
© 2016 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.